155 related articles for article (PubMed ID: 11796648)
1. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration.
Gardner JD; Ciociola AA; Robinson M
J Appl Physiol (1985); 2002 Feb; 92(2):427-34. PubMed ID: 11796648
[TBL] [Abstract][Full Text] [Related]
2. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
Feldman M
JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
[TBL] [Abstract][Full Text] [Related]
4. Reduction of postprandial gastric acidity and pepsin concentration by ranitidine and antacids in healthy volunteers.
Berstad A; Rydning A; Kolstad B; Frislid K
Scand J Gastroenterol Suppl; 1981 Jun; 69():67-73. PubMed ID: 6119785
[TBL] [Abstract][Full Text] [Related]
5. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
Gardner JD; Ciociola AA; Robinson M; McIsaac RL
Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
[TBL] [Abstract][Full Text] [Related]
6. Effect of gastric feeding on intragastric P(CO2) tonometry in healthy volunteers.
Kolkman JJ; Groeneveld AB; Meuwissen SG
J Crit Care; 1999 Mar; 14(1):34-8. PubMed ID: 10102722
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
Dammann HG; Burkhardt F
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
10. Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn.
Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
Aliment Pharmacol Ther; 2001 Sep; 15(9):1365-74. PubMed ID: 11552907
[TBL] [Abstract][Full Text] [Related]
11. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
Shimatani T; Inoue M; Kuroiwa T; Xu J; Nakamura M; Tazuma S; Ikawa K; Morikawa N
Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
[TBL] [Abstract][Full Text] [Related]
12. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
13. Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.
Gardner JD; Rodriguez-Stanley S; Robinson M; Miner PB
Aliment Pharmacol Ther; 2002 Oct; 16(10):1819-29. PubMed ID: 12269977
[TBL] [Abstract][Full Text] [Related]
14. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
[TBL] [Abstract][Full Text] [Related]
15. The effects of low doses of ranitidine on intragastric acidity in healthy men.
Wyeth JW; Pounder RE; Sercombe JC; Snell CC
Aliment Pharmacol Ther; 1998 Mar; 12(3):255-61. PubMed ID: 9570260
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
17. Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Bersenas AM; Mathews KA; Allen DG; Conlon PD
Am J Vet Res; 2005 Mar; 66(3):425-31. PubMed ID: 15822586
[TBL] [Abstract][Full Text] [Related]
18. The effect of the H2-antagonist niperotidine on intragastric acidity in healthy subjects undergoing 24-hour pH-monitoring.
Palasciano G; Maggi V; Portincasa P
Ital J Gastroenterol; 1990 Oct; 22(5):291-4. PubMed ID: 1983712
[TBL] [Abstract][Full Text] [Related]
19. Effect of gastric acid suppressants on human gastric motility.
Parkman HP; Urbain JL; Knight LC; Brown KL; Trate DM; Miller MA; Maurer AH; Fisher RS
Gut; 1998 Feb; 42(2):243-50. PubMed ID: 9536950
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
